Rimonabant: suicide and depression. Depression and suicidal tendencies are about twice as frequent with rimonabant as with placebo.
D003863:Depression / Q000139:chemically induced*; D006801:Humans; D009765:Obesity / Q000188:drug therapy*; D010880:Piperidines / Q000009:adverse effects* / Q000627:therapeutic use; D011720:Pyrazoles / Q000009:adverse effects* / Q000627:therapeutic use; D043884:Receptor, Cannabinoid, CB1 / Q000037:antagonists & inhibitors; D013405:Suicide / Q000523:psychology*; D014481:United States; D014486:United States Food and Drug Administration; D015431:Weight Loss / Q000187:drug effects
D010880:Piperidines; D011720:Pyrazoles; D043884:Receptor, Cannabinoid, CB1